MedTrace Logo

Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke

NCT02767999 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-08-28

No results posted yet for this study

Summary

Fluoxetine action on cerebral connectivity changes in acute ischemic stroke patients

Conditions

Interventions

DRUG

Fluoxetine

20 mg of fluoxetine capsule per day from D0 to D90

DRUG

Placebo

cellulose placebo per day from D0 to D90

RADIATION

fMRI

functional resting state MRI

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • François CHOLLET, MD PhD · University Hospital, Toulouse

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02767999 on ClinicalTrials.gov